Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy
Epidemiology and risk factors Venous thromboembolism (VTE) is a burdensome and frequent complication in patients with...
ARCHIVE
Is thrombosis of retinal veins a marker of occult cancer?
Although thrombosis of the retinal veins (either central or branch retinal vein thrombosis) is usually perceived as...
Risk of thromboembolism in cancer patients with Port-a-Cath. Results and implications of the ONCOCIP study
The normal experience of cancer patients who receive an implantable venous access device (Port-a-Cath) for chemotherapy...
A talking point for the CANTOS trial
A year after the results of the CANTOS trial were first presented, they were still an important talking point at ESC...
The big Gary Raskob interview
The wheres and whens of the GI bleeding HOKUSAI-VTE Cancer sub-analysis, the new paradigm of cardio-oncology and the...
An interview with Grigorios Gerotziafas
ISTH 2018 – Grigorios...
Disseminated Intravascular coagulation in solid and hematological cancers
Introduction There is a clear relationship between malignancy and deranged coagulation. Patients with cancer are at...
ISTH 2018 – Anna Falanga
Anna Falanga Chief of the Department of Immunohematology and Transfusion Medicine and the Thrombosis and Hemostasis...
Ingrid Pabinger at ISTH 2018
Ingrid Pabinger Professur für Hämostaseologie, Universitätsklinik für Innere Medizin I, Klinische Abteilung für...
ISTH 2018 – BETHANY SAMUELSON BANNOW
We met with Dr. Bethany Samuelson Bannow during the 64th Annual Scientific and Standardization Committee (SSC) meeting...